Respiratory Syncytial Virus Pediatric Hospitalization in the COVID-19 Era.
Int J Environ Res Public Health
; 19(23)2022 11 22.
Article
in English
| MEDLINE | ID: covidwho-2123621
ABSTRACT
Respiratory syncytial virus (RSV) globally affects the population, mainly young children, potentially causing hospitalization. During the COVID-19 pandemic, non-pharmacological measures interfered with the circulation of most respiratory viruses. Then, with the discontinuation of restrictive measures, a new scenario appeared. With this scoping review, we want to globally explore whether the RSV paediatric hospitalization rate was influenced by COVID-19. This scoping review was performed according to PRISMA guidelines on PubMed using the Mesh terms "Respiratory Syncytial Viruses"[Mesh] AND "COVID-19"[Mesh] OR "SARS-CoV-2"[Mesh]. Among them, we identified studies pertaining to children and adolescents up to 18 years old hospitalized for RSV, including 18 records in the revision. With the onset of the COVID-19 pandemic, a drastic reduction in RSV hospitalization among the pediatric population in 2020-2021 season has been observed in the Northern and Southern hemispheres. After the relaxing of restrictive measures, unexpected outbreaks happened, leading to increased hospitalization and occupation of pediatric intensive care units.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Syncytial Virus Infections
/
COVID-19
Type of study:
Observational study
/
Reviews
Limits:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Ijerph192315455
Similar
MEDLINE
...
LILACS
LIS